ILIAS Biologics ILIAS Therapeutics

(주)셀렉스라이프사이언스

About Us

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

  • Chulhee Choi(Chief Executive Officer)

    CEO

    MD-PhD, Microbiology, Yonsei University College
    of Medicine

    Neurologist

    Professor, Dept. of Bio and Brain Engineering, KAIST

    Published over 110 papers in major scientific journals

    Obtained 30 international patents

    Developed the world's first diagnostic medical device
    for diabetic peripheral vascular disease
    (L/O to Vieworks Co., Ltd., currently on the clinical trial)

    Established exosome-based protein drug delivery system
    platform technology

  • Cheol Hyoung Park(Head of R&D center)

    Head of
    R&D

    PhD, Neuropharmacology, College of Medicine,
    Seoul National University

    Former Principal Researcher, Dept. of drug development
    business, SK Biopharmaceuticals

    Professor, Dept. of Vet, Jeju National University

    Former director of GDFI Brain cell Laboratory Inc.

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기